Finally, we performed a secondary analysis to further evaluate the potential molecular mechanisms underpinning the AD risk-increasing effect of APOE ε4 carriage, versus the protective effect of ε2 carriage, when compared with ε3 homozygosity. This evidence concerns the gene APOE and Alzheimer disease.